Desk jobs increase risk of prostate cancer Aug 16, 2008
All the volunteers were questioned about the type of jobs they did and results revealed men in sedentary office jobs were 30 per cent more likely to have prostate cancer and 40 per cent more likely to have a non-cancerous condition called benign prostatic hyperplasia, or BPH.. This is a common disease in which the prostate becomes enlarged, making it difficult to urinate. (NEWS.com.au)
Best Practice Database Supports Bio-Pharma Product Launch Aug 12, 2008
One study, "Flomax Case Study: Evolving Disease State Awareness to Succeed with New Method of Action," reviews the strategy and tactics utilized by Boehringer-Ingelheim for the BPH (Benign Prostatic Hyperplasia) indicated product, Flomax/Tamsulosin, to differentiate the product and to boost disease awareness to expand the product market. By carving out a niche as a BPH-specific drug and motivating a large untapped patient pool through multiple communication tactics, Flomax achieved blockbuster... (PR Newswire)
Protox reports 2008 second quarter results Aug 11, 2008
"Protox continues to build on the success of the first quarter as the Company enrolls patients in two Phase 2 clinical trials of PRX302 for prostate cancer and benign prostatic hyperplasia (BPH). With the successful financing completed in May, Protox has been able to expedite the PRX302 BPH program and expect to complete enrollment ahead of schedule." said Dr. Fahar Merchant, President and CEO of Protox ... Although similar in amount, 2008 Q2 Rs reflect expenditures related to the PRX302 BPH and... (Canada Newswire)
Disclosure Document Aug 11, 2008
Rio Tinto and BPH Billiton have recently announced that they have settled with price increases of 79. 88% for fi nes and 96. (Sydney Morning Herald)
Oregon recreation report (15) Aug 10, 2008
Hunter harvest success was 2 birds per hunter (bph) Dec. 30, 1 ... 3 bph on Dec. 28 The most successful units for hunting during the past week are Mud Lake and Seal on the westside and Hunt, Rentenaar and Mudhen on the eastside ... 8 birds per hunter (bph) on Jan. 1, 2. (Lebanon Express, OR)
Understanding Prostate Disease Aug 6, 2008
The term Benign Prostatic Hypertrophy (BPH) is used to describe the condition - Benign indicating that the condition is NOT cancerous. BPH is quite common - research studies in many populations have shown that approximately forty percent of men over 60 suffer from BPH. ... We now know that BPH is not necessarily progressive. (Suite101.com)
New, Informative EAU Website Launched: http://www.urologyweek.org Jul 17, 2008
For 2008, Urology Week was set up with special focus; to ask attention for 3 key subjects: prostate conditions (especially BPH and prostate cancer), incontinence and erectile dysfunction. The EAU, the European knowledge centre of urology in Arnhem, The Netherlands, wishes to create more awareness of urological conditions and the work of the urologist amongst the general public. (PR Newswire)
QUESTIONS FOR HALL OF FAMER MIKE SCHMIDT Jul 15, 2008
talkaboutBPH.com) and the campaign itself is called the BPH Game Plan Starts with U: Catch the Whole Game. Were going to be going around the country pretty much associated with minor league baseball initially. (USA Today -- Sports)
Why men with desk jobs have higher risk of prostate cancer Jul 5, 2008
All the volunteers were questioned about the type of jobs they did, and the results revealed that men in sedentary office jobs were 30 per cent more likely to have prostate cancer and 40 per cent more likely to have a non-cancerous condition called benign prostatic hyperplasia, or BPH.. This is a common disease in which the prostate becomes enlarged, making it difficult to urinate. (Daily Mail)
THE YOU DOCS Jul 2, 2008
About 30 percent of men with BPH have symptoms (you've gotta go right now, often two or three times in the middle of the night) that do not progress. But 35 percent get better without treatment, and 35 percent get symptoms that are so bothersome they elect treatment. (OregonLive, OR -- News)
Prostate cancer sneaks up on victims Jun 30, 2008
This condition is called Benign Prostate Hypertrophy or Benign Prostate Hyperplasia (BPH, see related story on page 1A) ... According to , growth of the tumor is quite slow, and can be mistaken for BPH. Non-BPH symptoms are generally absent, and even a manual prostate exam conducted by the doctor s gloved index finger inside the patient s rectum may not detect anything beyond what could be a BPH condition. (Paragould Daily Press, AR)
Prevent prostate cancer with checkups Jun 30, 2008
Benign conditions include prostatitis, or an inflammation of the prostate, and benign prostatic hyperplasia (BPH) , or an enlargement of the prostate. In cases of BPH, the prostate will expand around the urethra ... We have to differentiate between the a BPH or a malignant prostatic hyperplasia. (Paragould Daily Press, AR)
Schmidt speaks out Jun 29, 2008
BPH is a progressive but manageable condition in which the prostate becomes enlarged, causing frequent and urgent urination, the need to urinate at night, weak urinary system and the feeling of incomplete bladder emptying ... Schmidt has teamed with Minor League Baseball and the pharmaceutical company sanofi-aventis to launch BPH Game Plan Starts With U: Catch the Whole Game to raise awareness of the condition. (The Citizen's Voice, PA)
Prostate Cancer: Why Every Man Ought To Be Concerned! Jun 25, 2008
Often, the DRE can be used by urologists to help distinguish between prostate cancer and non-cancerous conditions such as BPH (Prostate Cancer Foundation, 2008). BPH (Benign Prostatic Hyperplasia) is an inward, non-cancerous growth of the prostate that is rarely fatal, whereas prostate cancer is an outward growth of cells in the prostate, invading and destroying surrounding tissue (Prostate Cancer Foundation, 2008) ... Often, the DRE can be used by urologists to help distinguish between... (Ghana Web, Ghana)
Urodynamix Launches Tetra-NIRS Marketing Trials Jun 4, 2008
Founded in 1967 by Ray Laborie, Laborie Medical Technologies is the leading global manufacturer of urodynamics equipment used in the diagnosis and treatment of incontinence, BPH, and voiding dysfunction. As Laborie enters its 41st anniversary in business, it has established itself as 'the' supplier of pelvic floor assessment systems in many key academic centers. (CCNMatthews Press Releases)
Protox to present BPH data at AUA Conference May 20, 2008
VANCOUVER, May 20 /CNW/ - Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, today announced that preliminary data from the Phase 1 clinical study of PRX302 in patients with moderate to severe benign prostatic hyperplasia (BPH), will be presented at the 2008 Annual Meeting of the American Urological Association (AUA) ... About BPH BPH is a common urological condition characterized by painful and bothersome symptoms that include difficulty in... (Canada Newswire)
Urodynamix and Laborie Launch Tetra(TM) Bladder Monitor System May 20, 2008
Tetra is used in conjunction with other non-invasive tests (including uroflowmetry and bladder ultrasound) to assess bladder function and aid in the diagnosis of LUTS. These symptoms are particularly common in men with benign prostatic hyperplasia, or BPH (enlarged prostate), and Tetra provides clinicians with an alternative to more invasive, catheter-based procedures that are currently used to diagnose prostate obstruction and related conditions. "A urologist now has more options to diagnose... (CCNMatthews Press Releases)
Protox doses first patient in Phase 2 BPH clinical trial May 15, 2008
VANCOUVER, May 15 /CNW/ - Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, today announced the enrolment and successful dosing of the first patient in a Phase 2 clinical trial evaluating PRX302 to treat benign prostatic hyperplasia (BPH), or enlarged prostate, a common and bothersome urological condition that affects over 1 million men in Canada and over 50 million men worldwide ... "We are very pleased with the rapid advances we have made on... (Canada Newswire)
AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia May 14, 2008
QUEBEC CITY, May 14 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS; TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported dosing has commenced in the safety study of the Company's Phase 3 program with cetrorelix in benign prostatic hyperplasia (BPH) ... This 500-patient safety trial is the third of three Phase 3 studies - planned to enroll a total of 1,500 patients - to define the role of cetrorelix in the treatment of BPH, a non-cancerous... (Canada Newswire)
Emergent Group Inc. Reports First Quarter EPS of $0.08 On Record Sales May 14, 2008
The strong financial performance achieved by the Company last year continued into the first quarter of 2008 as we recorded our tenth consecutive quarter of year over year growth in sales,'' said Bruce J. Haber, Emergent Group Chairman and CEO. Mr. Haber added, ``Last year's financial accomplishment and the transition to our new and more profitable BPH Platform (Benign Prostatic Hyperplasia, representing approximately 21% of annual sales in 2007) helped grow Emergent sales to record levels in the... (Primezone Releases)
Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting May 13, 2008
YOKNEAM, Israel, May 13 /PRNewswire/ -- Lumenis Inc., a global developer, manufacturer and seller of laser, light-based and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced today the launch of a Holmium Laser Enucleation of the Prostate (HoLEP) preceptor program that will provide training opportunities for urologists who are interested in learning and performing HoLEP. The abundance of clinical evidence suggests that HoLEP provides superior outcomes in... (PR Newswire)
AEterna Zentaris: Article on Phase 2 Trial with Cetrorelix in BPH to be Published in European Urology Journal May 13, 2008
QUEBEC CITY, May 13 /CNW Telbec/ - AEterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that the article titled "Placebo-controlled dose-ranging Phase 2 study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia (BPH", has been accepted for publication in an upcoming issue of the European Urology Journal. Written by F.M.J. Debruyne, Department of... (Canada Newswire)
AEterna Zentaris Reports First Quarter 2008 Financial and Operating Results May 8, 2008
Juergen Ernst, Chairman, Interim President and CEO at AEterna Zentaris commented, "During the quarter, we continued to move forward with our Phase 3 program in BPH with our lead compound cetrorelix, as we completed patient recruitment for our first efficacy trial in North America and started patient dosing in our second similar efficacy trial in Europe. We also achieved an important milestone with our lead oncology compound AEZS-108, as we started patient dosing for our Phase 2 trial in... (Canada Newswire)
Parmalat, Limited Brands, Exxon Mobil, Siemens Bribery Case in Court News Apr 22, 2008
Polish Consumer Regulator to Probe Effects of Pekao-BPH Merger. Poland's consumer regulator will investigate whether the merger of 's Polish units, and Bank BPH SA, is violating customers' rights. (Bloomberg -- Germany)
Protox announces positive long-term data from BPH study Apr 16, 2008
VANCOUVER, April 16 /CNW/ - Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced positive results from its Phase 1 study evaluating PRX302 in patients with benign prostatic hyperplasia (BPH), a common and bothersome urological condition among the aging male population ... IPSS assesses the severity of seven key symptoms of BPH, (incomplete emptying, frequency, intermittency, urgency, weak stream, straining and nocturia) ... The... (Canada Newswire)
Microwave Treatments For Enlarged Prostate Cause Blood Pressure Surges, Study Shows Apr 12, 2008
Benign prostatic hyperplasia (BPH), or an enlarged prostate gland, is a condition affecting half of men over age 50 and 80 percent of those over 70 ... BPH often is treated with medication and in severe cases open surgery may be necessary, but since 1997 transurethral microwave therapy has been a less-invasive option ... (May 28, 2006) Injecting botulinum toxin A, or Botox, into the prostate gland of men with benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged... (Science Daily)
Protox Initiates Phase 2 BPH Study Apr 8, 2008
VANCOUVER, April 8 /CNW/ - Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, today announced that the Company has received Institutional Review Board (IRB) and Health Canada approvals to proceed with its Phase 2 clinical trial evaluating PRX302 for the treatment of benign prostatic hyperplasia (BPH) ... Results from the Phase 1 BPH study indicate that PRX302 is safe and well tolerated and shows very encouraging signs of therapeutic activity ...... (Canada Newswire)
Diabetic Men More Prone to Urinary Woes Mar 25, 2008
The investigators examined the associations between diabetes and signs of an enlarged prostate gland, a condition called benign prostatic hypertrophy, or BPH, that is quite common among older men and that can cause symptoms such as frequent urination and a weak urine stream. The study was made up of 2484 black and white men who were participating in studies designed to evaluate the natural history of BPH. Their average age was 56 years, and 170 (6. (MEDLINEplus)
Veggies and Alcohol May Reduce Prostate Problems Feb 25, 2008
As many as half of 50-year-old men have benign prostate hyperplasia (BPH), which causes frequent and sometimes painful urination, while up to 80% of 70 year olds have the condition, Dr. Alan R. Kristal of the Fred Hutchinson Cancer Research Center in Seattle and colleagues note in their report. The only established risk factor for BPH that people can do something about is obesity, particularly in the abdominal region ... To investigate whether dietary changes could be beneficial as well, Kristal... (Newsmax)
Nutrition and Prostate Health Feb 20, 2008
The most common prostate complication is benign prostatic hyperplasia (BPH), or enlargement of the prostate. BPH may cause frequent urination, excessive nocturia and reduced pressure when urinating ... While there are medications available for treatment of BPH, they are often accompanied with undesirable side effects. (Suite101.com)
What's Good for the Heart May Be Good for the Prostate Feb 13, 2008
Specifically, such a diet significantly decreases the risk of symptomatic benign prostatic hyperplasia, or BPH. The bothersome condition is associated with frequent and painful urination that affects about half of all men by the time they reach 50 and nearly all men by age 70 ... The study also found that eating four or more servings of vegetables daily was associated with a 32 percent reduction in risk, consuming high amounts of lean protein (about 20 percent of daily calorie intake) was... (PR Newswire)
County treasurer makes first court appearance today on drug charges (40) Feb 10, 2008
WE THE PEOPLE THINK wrote on Jan 15, 2008 4:06 PM:" Its about time all this was exposed, this has been going on a long time! Maybe they should give Stans job to Larry R. It sounds like he is an honest man, or maybe give Larry Linda Herdons or Gary Deckards job. Sounds like they should come down off their highhorses and not be so predjudiced against Some county employees. Good job, Larry and the BPH!!!! ". Way to Go wrote on Jan 15, 2008 1:37 PM:" I would like to say Congradulations to Chief Tom... (Bartlesville Examiner-Enterprise, OK)
Management of Prostate Cancer Jan 27, 2008
It could be prostate cancer, but it could also be benign prostatic hypertrophy (BPH), which involves a diffusely enlarged prostate without cancer, or prostatitis, which may result from infection of the prostate. In fact, a patient may be put on a trial of antibiotics if prostatitis is suspected; if the PSA drops after antibiotics, the cause is likely prostatitis. (Suite101.com)
Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone Jan 18, 2008
Enlarged prostate (also known as benign prostatic hyperplasia or BPH) is a progressive disease that affects 50 percent of men over the age of 50 and more than 90 percent of men over age 80 ... Enlarged Prostate (BPH) ... bph/BP99999/PAGE=BP00009. (PR Newswire)
NIH Panel Seeks To Dispel Stigma Associated With Fecal And Urinary Incontinence Dec 18, 2007
(May 28, 2006) Injecting botulinum toxin A, or Botox, into the prostate gland of men with benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, eases symptoms and improves. . (Science Daily)
High Death Toll After Severe Urinary Complications In Men Over 45 Nov 14, 2007
18, 2003) A combination of drugs is significantly more effective than either drug alone for preventing progression of benign prostatic hyperplasia (BPH), especially in men at high risk for disease progression ... (May 29, 2002) Two drugs commonly used to treat benign prostatic hyperplasia (BPH) are more effective in combination than alone to prevent progression of this condition, according to results of a multi-center. (Science Daily)
The Pearl dishes Nov 13, 2007
Monroe, 62, was among the more than 50 percent of men 50 or older who suffer from benign prostatic hyperplasia (BPH), better known as an enlarged prostate ... He also is leading a national campaign by the makers of Flomax, a drug that treats the symptoms of BPH, who have an online quiz to help men determine if they should talk to their doctor (Oneweekchallenge ... The Heat Index sat down with "The Pearl" to discuss BPH and, of course, hoops. (AZCentral -- Sports)
Ranbaxy settles patent infringement case Nov 9, 2007
The total annual sales of Flomax, indicated for the treatment of BPH (benign prostatie hyperplasia), is estimated to be $1. 2 billion. (Business Standard)
Enlarged prostate common in older men Oct 23, 2007
Condition is called BPH, or benign prostatic hyperplasia ... In fact we even see some cases of men in their 30s and 40s have some degree of what we call BPH or benign prostatic hyperplasia ... By the time you get to men in their 80s, nearly 80 percent or more have some degree of BPH.. (CNN -- Health)
Protox completes BPH trial recruitment and announces positive interim data Oct 3, 2007
VANCOUVER, Oct. 3 /CNW/ - Protox Therapeutics Inc. (TSX-V:PRX) today announced that it has completed recruitment of patients for its Phase 1 clinical trial evaluating PRX302 in males with benign prostatic hyperplasia (BPH) and reported positive interim data from this study ... "Patients with bladder outlet obstruction and lower urinary tract symptoms due to BPH are keen to seek non-surgical options," said Dr. Peter Pommerville, co-principal investigator at Can-Med Clinical Research Centre in... (Canada Newswire)
Pain meds may worsen symptoms of enlarged prostate Sep 22, 2007
Prostate enlargement, known as benign prostatic hyperplasia (BPH), is common among older men ... It's known that certain medications, most commonly cold and allergy remedies, can make BPH symptoms worse ... Now, a large study in the Netherlands recently implicated NSAIDs as another cause of worsening BPH, according to the Harvard publication. (Scientific American)
Man's health: The prostate gland Sep 17, 2007
Benign (not cancerous) enlargement of the prostate (BPH for short) ... As men get older their prostate gland tends to enlarge, a condition that is medically referred to as benign prostatic hyperplasia (BPH). (Times of Malta)
Prostate cancer awareness week, US Sep 17, 2007
Monday, Sept. 17 -- General Prostate Cancer Awareness Day Tuesday, Sept. 18 -- Advanced Prostate Cancer Awareness Day Wednesday, Sept. 19 -- Benign Prostatic Hyperplasia (BPH) Awareness Day Thursday, Sept. 20 -- Women, Families ivers Day Friday, Sept. 21 -- Know Your Numbers (Cholesterol, Testosterone, Obesity tion) Day Saturday, Sept. 22 -- New Horizons (Innovation, Research ing Treatment Options) Day. (Posted on Saturday, September 15, 2007). (SpiritIndia)
New Urine Test ID's Prostate Cancer Sep 16, 2007
If a man has an enlarged prostate -- a noncancerous condition called benign prostatic hyperplasia or BPH -- his PSA level can go up ... "The beauty of this test is it seems to be independent of the BPH component," Mark Emberton, MD, of the Institute of Urology at University College London, tells WebMD. "But it is not a perfect test. It does not rule out -- or rule in -- clinically meaningful disease." ... The studies showed that the PCA3 test isn't influenced by the size of the prostate, even in... (Yahoo News -- Prostate Cancer)
PM undergoes surgery for prostate Sep 16, 2007
Speaking to TOI, doctors who operated on the Prime Minister said, "Singh was suffering from benign prostatic hypertrophy (BPH) for the past three years. He will be completely alright now." Previously, he has had two minor surgeries on both wrists at the institute. BPH is common with aging ... This second growth phase often results, years later, in BPH.. (Times of India)
NSAIDS May Raise Risk of BPH Sep 6, 2007
Men with slow urine flow from enlargement of the prostate gland (known as benign prostatic hyperplasia or BPH) should avoid anything that makes the situation worseand that includes some medications ... By contrast, though, researchers in America evaluating the long-term effects of NSAIDs on the prostate found that daily NSAID use was linked to a reduced risk of developing BPH symptoms and slow urinary flow rates ... At first glance the studies seem contradictory, but a closer look suggests that... (Newsmax)
Protox releases Q2 2007 financial results and company highlights Aug 30, 2007
QUICK SEARCH BY ORGANIZATION. FREE SUBSCRIPTION SERVICES. (Canada Newswire)
Prostate Cancer and Ejaculation Aug 4, 2007
Prostates normally enlarge with age; this is known as benign prostatic hyperplasia (BPH). With some men this enlargement becomes a slow-growing cancer that stays localized in the prostate. (Suite101.com)
The 30 Minute Diabetes Cure?! Jul 29, 2007
Equally fine results for BPH. The International Hospital has been using it for 7 years to treat benign prostate swelling. Their urologists track results very thoroughly, even measuring prostate size. (Newsmax)
Shareholder Class Action Filed Against Threshold Pharmaceuticals, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP Jul 19, 2007
According to the defendants, Metabolic Targeting could be used in the treatment of cancer and benign prostatic hyperplasia ("BPH") ... More specifically, the Complaint alleges that the Company failed to disclose and misrepresented the following material adverse facts which were known to defendants or recklessly disregarded by them: (1) that results of the European Phase II study failed to properly reflect TH-070's impact on the different types of BPH; (2) that based on clinical study results,... (PR Newswire)
Many Men Getting Unnecessary Prostate Cancer Blood Tests Jul 11, 2007
PSA level is affected by many other factors besides cancer, including an enlarged prostate or benign prostatic hyperplasia (BPH) ... "But once BPH starts, PSA readings become less predictive, especially for older men," he added. (MEDLINEplus)
Schatz Nobel Izard P.C. Announces Class Action Lawsuit Against Threshold Pharmaceuticals, Inc. Jul 10, 2007
Specifically, in preparation for the IPO, defendants conducted a so-called ``Phase II'' study of TH-070, its lead product candidate for the treatment of symptomatic benign prostatic hyperplasia (``BPH''), at Bari University in Italy ... However, on May 11, 2006, defendants disclosed that the FDA had placed the TH-070 program on partial clinical hold as a result of abnormalities observed in liver enzyme levels in six subjects in ongoing clinical trials and had requested additional information... (Primezone Releases)
Complaint charges Threshold made misleading statements Jul 7, 2007
However, on May 11, 2006, Threshold disclosed that the FDA had placed the TH-070 program on partial clinical hold as a result of abnormalities observed in liver enzyme levels in six subjects in ongoing clinical trials and had requested that the company provide additional information related to the drug's acceptable dose and duration of treatment in BPH patients. According to the complaint, while defendants "had known for years of TH-070's propensity to cause liver toxicity, the IPO and follow-on... (San Jose Business Journal)
The Brualdi Law Firm Announces Class Action Lawsuit Against Threshold Pharmaceuticals, Inc. Jul 7, 2007
During the Class Period, the Company's lead product candidate for the treatment of symptomatic benign prostatic hyperplasia (``BPH'') was TH-070, a drug which utilized Threshold's patented Metabolic Targeting process ... However, on May 11, 2006, defendants were forced to disclose that the FDA had placed the TH-070 program on partial clinical hold as a result of abnormalities observed in liver enzyme levels in six subjects in ongoing clinical trials and had requested that the Company provide... (Primezone Releases)
Boston Scientific Purchases Prostate Treatment Technology from Celsion Corporation Jun 22, 2007
June 21 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: ) today announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia (BPH, often referred to as enlarged prostate) from Celsion Corporation (Amex: ), following approval of the acquisition by Celsion stockholders at the company's annual meeting on June 13 ... BPH affects many men over the age of 50 and can have a significant impact on quality of life including a frequent need to urinate and... (PR Newswire)
Botox May Help Ease Bladder Problems May 25, 2007
Chuang, Chancellor and their team studied 37 men (average age 67) who did not do well on the medications commonly prescribed to help relieve the urinary problems associated with an enlarged prostate, a condition called benign prostatic hyperplasia, or BPH. The prostate gland surrounds the urine-carrying tube or urethra ... Common symptoms of BPH include weak urine stream, leaking or dribbling, feeling that the bladder hasn't emptied completely after voiding, and more frequent urination ... Now,... (CBS News)
Men With Enlarged Prostate Can Benefit From Botox Injections Up To A Year After Treatment May 25, 2007
The study, based on 37 men with benign prostatic hyperplasia (BPH), was presented at the annual meeting of the American Urological Association (AUA) in Anaheim, Calif ... The study participants, previously diagnosed with symptomatic BPH that did not respond to standard medical treatment, received injections of Botox directly into their prostate glands ... BPH is one of the most common diseases affecting men as they age. (Science Daily)
Botox Could Treat Enlarged Prostate May 24, 2007
The small study revealed that about 75 percent of men suffering from benign prostatic hyperplasia (BPH) experienced partial symptom relief following the treatment ... According to the National Kidney and Urologic Diseases Information Clearinghouse, BPH usually occurs among men over the age of 50 ... More than half of all men over the age of 60 develop BPH, the authors noted -- a figure that rises to 80 percent by the age of 80. (Health-Finder)
AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2 Data for Ozarelix, in BPH at Annual AUA Meeting May 23, 2007
Ozarelix improved LUTS symptoms and urine flow over 28-week period All amounts are in U.S. dollars QUEBEC CITY, May 23 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ; NASDAQ: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its partner Spectrum Pharmaceuticals (NASDAQ: SPPI) presented an abstract outlining detailed Phase 2 results for AEterna Zentaris' fourth-generation luteinizing hormone-releasing hormone (LHRH/GnRH) antagonist,... (Canada Newswire)
Lumenis Launches 'The Power of One' for VersaPulse(R) PowerSuite(TM) at American Urology Association 2007 Annual Meeting May 16, 2007
"Lumenis' unmatched expertise in holmium laser technology has resulted in products suitable for a wide range of urology applications in various treatments. Industry estimates suggest Endoscopic Procedures to be $100M per annum and climbing at a rate of 34% world-wide," informed Mr. Diamond, who added: "Lumenis' VersaPulse PowerSuite was specifically designed to be a comprehensive clinical solution for Urologists and their patients. AUA attendees will be excited to learn of the broad therapeutic... (PR Newswire)
Urologic Diseases Price Tag: $11B In 2000 May 3, 2007
Benign prostatic hyperplasia (BPH, or enlarged prostate): $1. 1 billion. (CBS News)
New Prostate Cancer Test Better than PSA Apr 27, 2007
Getzenberg and his team measured EPCA-2 levels in the blood of 330 Hopkins patients separated into several groups: men with normal PSA levels and no evidence of disease; men with elevated PSA levels but who had negative biopsies, men with a common noncancerous prostate condition known as benign prostatic hypertrophy (BPH) who did not receive biopsies for prostate cancer, men with prostate cancer but with normal PSA levels, men with prostate cancer confined to the prostate, men with prostate... (Newsmax)
AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH Apr 19, 2007
All amounts are in US dollars QUEBEC CITY, April 19 /CNW Telbec/ - AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused on endocrine therapy and oncology, today reported dosing has commenced with its flagship product candidate, cetrorelix, the Company's lead luteinizing hormone-releasing hormone (LHRH) antagonist compound, in the first study of its Phase 3 program in benign prostatic hyperplasia (BPH). As previously announced, the first study of the Phase 3... (Canada Newswire)
Stocks Decline, Led by Westfield on Stronger Currency; Woodside Advances Apr 13, 2007
BioPharmica Ltd. (BPH AU), a biotechnology company that develops products used for the treatment and diagnosis of cancer, gained 1. 5 cents, or 15 percent, to 11. (Bloomberg -- Australia & New Zealand)
Ex-NBA star dishes advice on men's health Apr 7, 2007
"It could be BPH or prostate cancer. You don't know until you see a doctor.". Monroe was in Orlando on Friday to promote the African-American Men's Health Summit today at the Orange County Convention Center. (Orlando Sentinel -- News)
